As a newly introduced category, this award recognises innovation that responds to the evolving needs of women’s health throughout the lifespan. We are honoured that Ubiquinol has been acknowledged for its role in supporting energy production, vitality, cardiovascular health, and overall wellbeing — all underpinned by the science of mitochondrial health.
This nomination reflects the work of many — from researchers, R&D, Manufacturing, to Brandholder partners and KOLs — who continue to explore how targeted mitochondrial support can make a meaningful difference in women’s health across life stages, from pre-conception to menopause.
Congratulations to all fellow finalists and our gratitude to NutraIngredients-Asia and the judging panel.
NATIONAL PHARMACISTS CONVENTION 2025 Uniting Pharmacy to Advance Health Through Innovation and Evidence-Based Practice 25–27…
Kaneka Ubiquinol™ at AFCC 2025: Advancing Cardiovascular Innovation through Mitochondrial Science 17–20 July 2025 |…
15–17 July | Marina Bay Sands, Singapore As the science of healthy ageing continues to…
Kaneka Ubiquinol™ is pleased to participate in the upcoming ACNEM 2025 Annual Conference, taking place…
Underscoring Kaneka Ubiquinol™’s ongoing commitment to excellence in the natural health industry Christchurch, New Zealand,…
How can we age well, especially in the face of stress, nutrient depletion, and daily…